WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock Ownership - Who owns Fennec Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fennec Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Terry L. EvansCCO2026-10-122,326$5.53
$12.86kBuy
Pierre Sargis SayadMed2026-10-123,846$5.53
$21.27kBuy
Robert AndradeCFO2026-10-123,846$5.53
$21.27kBuy
Jeffrey S. HackmanCEO2026-10-122,224$5.53
$12.30kBuy
Christiana Marie CioffiCStrat2026-10-123,946$5.53
$21.82kBuy
Marco Maria BrugheraDirector2026-09-1515,545$2.11
$32.80kBuy
Marco Maria BrugheraDirector2026-09-1515,545$10.29
$159.96kSell
Rosty RaykovInsider2026-09-0110,000$12.11
$121.10kSell
Pierre Sargis SayadMed2026-08-3112,000$12.18
$146.16kSell
Robert AndradeCFO2026-08-2821,928$5.10
$111.83kBuy

1 of 4

FENC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FENC insiders and whales buy or sell their stock.

FENC Shareholders

What type of owners hold Fennec Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Southpoint Capital Advisors LP578.16%202,744,741$2.22BInsider
Robert W. Butts355.07%124,512,000$1.36BInsider
Southpoint Master Fund LP11.40%3,997,214$43.77MInsider
Spa Essetifin11.39%3,993,694$43.73MInsider
Manchester Management Co LLC6.23%2,184,023$23.92MInsider
Manchester Management Pr LLC6.23%2,184,023$23.92MInsider
William G. Breen3.90%1,367,781$14.98MInsider
Fred H. Mermelstein3.89%1,363,410$14.93MInsider
Robert Andrade0.70%246,855$2.70MInsider
Khalid Islam0.61%213,825$2.34MInsider

1 of 3

FENC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FENC0.00%100.00%Net SellingNet Selling
OBIO0.05%67.06%Net SellingNet Selling
CTNM0.08%7.14%Net SellingNet Buying
AGMB0.05%0.26%Net BuyingNet Buying
MPLT0.05%99.95%Net BuyingNet Buying
View Top Biotech Stocks

Fennec Pharmaceuticals Stock Ownership FAQ

Who owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals (NASDAQ: FENC) is owned by 0.05% institutional shareholders, 979.18% Fennec Pharmaceuticals insiders, and 0.00% retail investors. Southpoint Capital Advisors LP is the largest individual Fennec Pharmaceuticals shareholder, owning 202.74M shares representing 578.16% of the company. Southpoint Capital Advisors LP's Fennec Pharmaceuticals shares are currently valued at $2.08B.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.